Business Description
BillionToOne is a California-based diagnostics company founded in 2016 that uses advanced DNA measurement technology to improve how diseases are detected and monitored. Its products include a prenatal blood test that screens for genetic conditions in unborn babies, as well as cancer tests that identify tumor mutations and track how well a patient is responding to treatment. These cancer tests work without requiring a tissue sample, making them less invasive while still delivering highly accurate results.
